NPY-(13-36) (human)
| SMILES | None |
| InChIKey | WNYKZOWMSHGMPJ-YGPTWXQHSA-N |
| Sequence | PAEDMARYYSALRHYINLITRQRY |
Chemical properties
| Hydrogen bond acceptors | None |
| Hydrogen bond donors | None |
| Rotatable bonds | None |
| Molecular weight (Da) |
Drug properties
| Molecular type | Peptide |
| Endogenous/Surrogate | Surrogate |
| Approved drug | No |
Database connections
Bioactivities
| Receptor | Activity | Source | |||||||
|---|---|---|---|---|---|---|---|---|---|
| GTP | Uniprot | Species | Family | Class | Type | Min | Avg | Max | Database |
| Receptor | Activity | Source | |||||||
|---|---|---|---|---|---|---|---|---|---|
| GTP | Uniprot | Species | Family | Class | Type | Min | Avg | Max | Database |
| P2Y2 | P2RY2 | Rat | P2Y | A | pEC50 | 6.89 | 6.89 | 6.89 | ChEMBL |
| P2Y4 | P2RY4 | Human | P2Y | A | pEC50 | 5.6 | 6.79 | 7.41 | ChEMBL |
| P2Y2 | P2RY2 | Human | P2Y | A | pEC50 | 4.69 | 6.93 | 8.25 | ChEMBL |
| P2Y2 | P2RY2 | Human | P2Y | A | pEC50 | 8.09 | 8.09 | 8.09 | Drug Central |
| P2Y2 | P2RY2 | Human | P2Y | A | pEC50 | 8.1 | 8.1 | 8.1 | Guide to Pharmacology |
| P2Y4 | P2RY4 | Human | P2Y | A | pEC50 | 8.2 | 8.2 | 8.2 | Drug Central |
| P2Y4 | P2RY4 | Human | P2Y | A | pEC50 | 6.3 | 6.3 | 6.3 | Guide to Pharmacology |
| P2Y6 | P2RY6 | Human | P2Y | A | pEC50 | 8.28 | 8.28 | 8.28 | Drug Central |
| P2Y6 | P2RY6 | Human | P2Y | A | pEC50 | 5.22 | 5.6 | 6.37 | ChEMBL |
| P2Y6 | P2RY6 | Human | P2Y | A | pEC50 | 5.2 | 5.2 | 5.2 | Guide to Pharmacology |
| P2Y11 | P2Y11 | Human | P2Y | A | pEC50 | 8.28 | 8.28 | 8.28 | Drug Central |
| P2Y11 | P2Y11 | Human | P2Y | A | pEC50 | 5.2 | 5.2 | 5.2 | Guide to Pharmacology |
| P2Y2 | P2RY2 | Mouse | P2Y | A | pEC50 | 5.9 | 5.9 | 5.9 | ChEMBL |
| P2Y2 | P2RY2 | Mouse | P2Y | A | pIC50 | 5.82 | 5.82 | 5.82 | ChEMBL |
| P2Y4 | P2RY4 | Rat | P2Y | A | pEC50 | 8.25 | 8.25 | 8.25 | Drug Central |
| P2Y4 | P2RY4 | Rat | P2Y | A | pEC50 | 5.58 | 5.58 | 5.58 | ChEMBL |
| P2Y4 | P2RY4 | Rat | P2Y | A | pEC50 | 5.6 | 5.6 | 5.6 | Guide to Pharmacology |